Rutgers Office for Research proudly presents you with the Technology Transfer Bulletin, which will provide updates on Rutgers innovations and highlight collaborative and partnership opportunities for

intellectual property-based assets.

Biodegradable Scaffold for Advanced Stem Cell Therapy

Rutgers-Advanced Stem Cell Therapy


This new stem cell technology with controlled drug delivery promotes functional recovery from spinal injuries.


Learn more about this technology

Novel SARS-CoV2 Neutralizing Human Monoclonal Antibody (HUMAB)

This new broadly reactive HUMAB works against a wide array of current variants (and sub-variants) at an incredibly small dose.


Read more

Highly Effective Anti-fungal Protein for Turfgrass Lawns

An eco-friendly treatment to keep your grass/lawn beautiful and healthy all season long.


Read more

Generate High-quality and Privacy-Protecting Synthetic Data

An AI technology to generate high-fidelity data from real data with missing values.


Read more

Near-infrared Photocatalyst Based on TiO2-coated Gold Nanoparticles

A new technology that enhances photosynthetic production can offer a potential solution to renewable energy.


Read more

Startups


Start-ups incorporated from technologies developed at Rutgers University

NemaGen Discoveries

NemaGen is a Rutgers startup that develops strategies to alleviate discomfort caused by allergic inflammation and mast cell-related diseases.


Learn more

Derisked through Commercialization Grants


Available technologies that received Rutgers Gap Funding awards

Electrostatic Screen Battery for Emission Control

Take a deep breath: this clean green technology removes up to 99% of airborne pollutants emitted by diesel engines.


Read more

Gsx1Gene Therapy for Spinal Cord Injury

This safe and effective gene therapy accelerates healing from spinal cord injuries.


Read more


Learn more about Innovation Ventures
LinkedIn  Twitter  Facebook